General Information of Drug Transporter (DT)
DT ID DTD0115 Transporter Info
Gene Name SLC17A2
Transporter Name Sodium-dependent phosphate transport protein 3
Gene ID
10246
UniProt ID
O00624

Transcriptional Regulation of This DT (TSR)

TF Superclass1: Basic domains

      Class1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        CEBPB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC17A2 gene [1]

TF Protein Name

CCAAT/enhancer-binding protein beta Transcription Factor Info

Tissue

Blood; Bone marrow; Breast; Cervix; Colon; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC17A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent phosphate transport protein 3.

TF Superclass2: Zinc-coordinating DNA-binding domains

      Class2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        AR 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC17A2 gene in prostate cancer condition [2]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC17A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3.

       Transcriptional Phenomenon2

Binding to SLC17A2 gene [3]

TF Protein Name

Androgen receptor Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC17A2 gene in . condition, which leads to a affected expression of the drug transporter Sodium-dependent phosphate transport protein 3.

        HNF4A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC17A2 gene in health condition [4]

TF Protein Name

Hepatocyte nuclear factor 4-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC17A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3.

TF Superclass3: Helix-turn-helix domains

      Class3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        FOXA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC17A2 gene in prostate carcinoma condition [5]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC17A2 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3.

        FOXA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC17A2 gene in health condition [4]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC17A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3.
References
1 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-215. (ID:ENSG00000112337)
2 Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor. Oncotarget. 2012;3(2):183-94.
3 Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 2010;29(13):2147-60.
4 Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 2009;37(22):7498-508.
5 SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. Nucleic Acids Res. 2015;43(2):848-61.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.